1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemia
    Journal Article

    Strickland, S. A.; Wang, X. V.; Cerny, J.; Rowe, J. M.; Rybka, W.; Tallman, M. S.; Litzow, M.; Lazarus, H. M.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study
    Journal Article

    Hamilton, E.; O'Malley, D. M.; O'Cearbhaill, R.; Cristea, M.; Fleming, G. F.; Tariq, B.; Fong, A.; French, D.; Rossi, M.; Brickman, D.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Huh, W. K.; Brady, W. E.; Fracasso, P. M.; Dizon, D. S.; Powell, M. A.; Monk, B. J.; Leath, C. A. 3rd; Landrum, L. M.; Tanner, E. J.; Crane, E. K.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Axitinib plus immune checkpoint inhibitor: Evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events
    Guidelines

    Grünwald, V.; Voss, M. H.; Rini, B. I.; Powles, T.; Albiges, L.; Giles, R. H.; Jonasch, E.
    British Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib in RET-altered thyroid cancers
    Journal Article

    Wirth, L. J.; Sherman, E.; Robinson, B.; Solomon, B.; Kang, H.; Lorch, J.; Worden, F.; Brose, M.; Patel, J.; Leboulleux, S.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib in RET fusion-positive non-small-cell lung cancer
    Journal Article

    Drilon, A.; Oxnard, G. R.; Tan, D. S. W.; Loong, H. H. F.; Johnson, M.; Gainor, J.; McCoach, C. E.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • A phase II trial of cabozantinib in hormone receptor-positive breast cancer with bone metastases
    Journal Article

    Xu, J.; Higgins, M. J.; Tolaney, S. M.; Come, S. E.; Smith, M. R.; Fornier, M.; Mahmood, U.; Baselga, J.; Yeap, B. Y.; Chabner, B. A.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
    Research Letter

    Sawas, A.; Ma, H.; Shustov, A.; Hsu, P.; Bhat, G.; Acosta, M.; Horwitz, S.; O’Connor, O. A.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): A double-blind, randomised, placebo-controlled, phase 3 trial
    Journal Article

    Blay, J. Y.; Serrano, C.; Heinrich, M. C.; Zalcberg, J.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Clinical and radiographic presentations of COVID-19 among patients receiving radiation therapy for thoracic malignancies
    Journal Article

    Samson, P.; Ning, M. S.; Shaverdian, N.; Shepherd, A. F.; Gomez, D. R.; McGinnis, G. J.; Nitsch, P. L.; Chmura, S.; O'Reilly, M. S.; Lee, P.; more...
    Advances in Radiation Oncology (2020)

    Fulltext@MSK | Save